GlassScriptPhysician profile
Alisha M Mortenson
NPI 1134923238
$1,358.93
in general payments reported to CMS, 2019-2025
14 companies · $1,359 in 2025
The $1,359 reported for 2025 was more than what 85% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,358.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $182.29 | 2025 | Airsupra, Breztri |
| Novo Nordisk INC | $180.06 | 2025 | Wegovy, Rybelsus, Ozempic |
| Pfizer INC. | $164.56 | 2025 | |
| Inspire Medical Systems, INC. | $162.41 | 2025 | Inspire |
| Si-Bone, INC. | $137.36 | 2025 | |
| Genzyme Corporation | $121.84 | 2025 | |
| Providence Medical Technology, INC. | $119.16 | 2025 | |
| Glaxosmithkline, LLC. | $65.88 | 2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $57.89 | 2025 | Jardiance |
| Lilly USA, LLC | $47.84 | 2025 | Zepbound, Mounjaro |
| Alnylam Pharmaceuticals INC. | $47.51 | 2025 | Amvuttra |
| Cranial Technologies, INC | $40.33 | 2025 | Doc Band |
| Exact Sciences Corporation | $18.28 | 2025 | The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $13.52 | 2025 | Gardasil 9, Capvaxive |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alisha Mortenson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.